Generic Pharmaceutical Patent and FDA Law
Generic Pharmaceutical Patent and FDA Law covers Food and Drug Administration approval of generic drugs and the interaction of patents […]
Generic Pharmaceutical Patent and FDA Law Read Post »
Generic Pharmaceutical Patent and FDA Law covers Food and Drug Administration approval of generic drugs and the interaction of patents […]
Generic Pharmaceutical Patent and FDA Law Read Post »
This article was originally published by Philippe Lahorte in World Patent Information Volume 54, Supplement, September 2018, Pages S18-S22 Under
Inside the mind of an EPO examiner Read Post »
We thought you might be interested in some of the great reviews we’re getting over at software review site G2Crowd.
See What Others are Saying About DrugPatentWatch Read Post »
DrugPatentWatch, a provider of global biopharmaceutical business intelligence, has entered into a partnership with Adis. The partner will enhance Adis’
DrugPatentWatch Partners with Adis: Helping Drug Companies Make Better Decisions Read Post »
Branded generics are generic drugs that have been given proprietary brand names. They have a small, but profitable place in the U.S. pharmaceutical market.
Branded Generics: What They Are and Why They’re Profitable Read Post »
Kenneth L. Dorsney, Editor-in-Chief 1,035 pages Buy from Amazon Pre-ANDA litigation is the companion to ANDA Litigation, which I recommend
Pharmaceutical life cycle management begins earlier and ends later to maximize stakeholder value in all phases of drug development.
How Pharmaceutical Life Cycle Management Strategies Are Evolving Read Post »
Get fresh news and insights, drug patent expirations & more…